HCPCS J1652: Fondaparinux Sodium Injection, 0.5 mg
HCPCS Level II code J1652 describes an injection of fondaparinux sodium, 0.5 mg used for anticoagulant therapy; the service is a parenteral medication administration typically provided in hospital inpatient, emergency department, or outpatient infusion/observation settings and is billed per unit corresponding to the 0.5 mg dosage.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J1652 policy alerts
Get alerted when payer policies referencing J1652 are released or updated.
Monitor payer policy activity